Congressman John Sarbanes (D-Md.) and the Baltimore Congressional Delegation today announced $162,283 in federal funding for Johns Hopkins University (JHU) to conduct research into the replication process of SARS-CoV-2, the virus that causes the 2019 novel coronavirus disease (COVID-19).
This research will advance efforts to design effective therapies while guarding against the possibility of drug resistance through viral mutation. The funding was authorized by the Coronavirus Aid, Relief and Economic Security (CARES) Act.
“Like many other Maryland research institutions, Johns Hopkins is leading the way in finding effective therapies for the tens of thousands of Americans who have contracted COVID-19, and for those who will contract it in the future,” the lawmakers said. “Federal investments in high-caliber research projects like this one are absolutely critical in order to save lives and to help our society move beyond this pandemic.”
This year-long grant funding will begin on June 1, 2020. See here for a full abstract and additional information about the award.
The CARES Act authorized $75 million to the National Science Foundation (NSF) to prevent, prepare for and respond to coronavirus, domestically or internationally, including to fund research grants and other necessary expenses. NSF is allocating funding to support research at molecular, cellular, physiological and ecological levels to better understand coronavirus genetics, modes of action, transmission, virulence and population dynamics.
The delegation previously announced federal funding to support the Johns Hopkins COVID-19 tracker.